Richard W. Dugan, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 15,000 shares at $14.85 ($223K) on 2019-08-26, disclosed to the SEC on 2019-08-28.
Open-market sale of $223k VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VNDA | SELL | 2020-05-29 | $224K | — | Filing → |
| VNDA | SELL | 2015-03-10 | $51K | — | Filing → |